Utilization Patterns of Pulmicort in Real Life Practice
NCT00660569 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 260
Last updated 2010-12-01
Summary
The purpose of this study is to identify the potential issues during short and mid term utilization of Pulmicort hydro fluoroaklane (HFA) pressurized metered-dose inhaler (pMDI)and describe associated factors.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Javier Nuevo Rivero · AstraZeneca MC SpainEpidemiologyValue Demonstration Unit
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-01-31
- Completion
- 2009-02-28
Countries
- Spain
Study Locations
More Related Trials
-
Pulmicort Turbuhaler 100/200 Specific Clinical Experience Investigation
NCT01203904 ·Status: COMPLETED
-
Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone & Formoterol Administered Alone in Patients With Asthma
NCT00394199 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Inhaled Glucocorticosteroid Administration in Asthma Patients
NCT00559689 ·Status: COMPLETED
-
A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive
NCT06433921 ·Status: RECRUITING ·Phase: PHASE1
-
Therapeutic Relevance of Abnormal Airway Morphology in Asthma
NCT06970080 ·Status: RECRUITING ·Phase: PHASE4
-
A Study to Assess the Efficacy of Inhaled Corticosteroid (ICS) Therapy in Moderate-Severe Bronchial Asthma
NCT00411567 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A 3-week Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With Asthma
NCT00130351 ·Status: COMPLETED ·Phase: PHASE3
-
New Version Pulmicort Turbuhaler USA Adults
NCT00642187 ·Status: COMPLETED ·Phase: PHASE3
-
Launching an Asthma Initiative Designed to Improve Asthma Management and Outcomes
NCT02140671 ·Status: UNKNOWN
-
Symbicort Single Inhaler Therapy for Asthma in a General Practice Setting
NCT00235911 ·Status: COMPLETED ·Phase: PHASE3
-
Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy
NCT00319306 ·Status: COMPLETED ·Phase: PHASE3
-
Optimal Type of Inhaler in Cough Variant- or Cough Predominant Asthma
NCT04203472 ·Status: COMPLETED ·Phase: NA
-
Open-label, Safety and Efficacy Study of Pulmicort® Turbuhaler® in Japanese Children With Bronchial Asthma
NCT00504062 ·Status: COMPLETED ·Phase: PHASE3
-
Real-world Effectiveness of Combination Therapy in Asthma
NCT01141465 ·Status: COMPLETED
-
Effect of Ciclesonide on Quality of Life in Patients With Moderate Persistent Asthma (21 to 65 y) (BY9010/AR-101)
NCT00305461 ·Status: COMPLETED ·Phase: PHASE3
-
A 12-Week Study in Adult Subjects With Asthma
NCT01516086 ·Status: COMPLETED ·Phase: PHASE2
-
New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma
NCT00393952 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma
NCT01436071 ·Status: COMPLETED ·Phase: PHASE3
-
12-Week Study in Adult Subjects With Asthma
NCT01516073 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Efficacy and Safety of Pulmicort Respules in Japanese Adult Asthmatic Patients
NCT00855959 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Asthma Relapse After Discharge From Emergency
NCT00326053 ·Status: COMPLETED ·Phase: PHASE3
-
Does Inhaled Busedonide or Fluticasone Impair Adrenal Function?
NCT00560625 ·Status: TERMINATED
-
New Version Pulmicort Turbuhaler USA Children
NCT00642161 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Effectiveness of a Breath-operated Albuterol Inhaler in Asthma Patients With Poor Inhaler Technique
NCT00054964 ·Status: COMPLETED ·Phase: PHASE2
-
A Cumulative Dose Study to Evaluate the Safety and Efficacy of Albuterol in a Dry Powder Inhaler and an HFA MDI (Hydrofluoroalkane Metered Dose Inhaler)
NCT01056159 ·Status: COMPLETED ·Phase: PHASE1